Abterra Biosciences
PrivateLast Round
Grant
Sep 20, 2024
Total Funding Raised
$4.01M
Company Overview
Abterra Biosciences operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Grant round in September 2024.
Abterra Biosciences is a biotechnology company that provides antibody sequencing and discovery services using next-generation sequencing, mass spectrometry, and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abterra Biosciences Comparables
Compare Abterra Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rapid Novor Inc. | 90% | |
| Creative Biolabs | 84% | |
| Creative Proteomics | 81% |
For institutional investors. Book with your work email.
Abterra Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 20, 2024 | ||||
| Seed | May 1, 2021 | ||||
| Grant | Feb 1, 2021 | ||||
| Grant | Feb 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Abterra Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Seattle Angel Conference | Seed |
| San Diego Angel Conference | Seed |
| Seattle Angel Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 74% MoM.
- Jan 21, 2026
Monthly visitors increased 30% MoM, reaching 1.9K.
For institutional investors. Book with your work email.
Abterra Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Abterra Biosciences's valuation, stock price, and market status.
Is Abterra Biosciences a public or private company?
Abterra Biosciences is a private company.
What is the current stock price of Abterra Biosciences?
Abterra Biosciences is a private company, so its shares have no public market price. Caplight tracks Abterra Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Abterra Biosciences worth (valuation)?
Valuation information for Abterra Biosciences is not publicly available.
Can I buy Abterra Biosciences stock?
Abterra Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Abterra Biosciences's last funding round?
Abterra Biosciences's most recent funding round was Grant on September 20, 2024.
Who are the main investors in Abterra Biosciences?
Key investors in Abterra Biosciences include NIH RADx.
Will Abterra Biosciences IPO soon?
No public IPO plans have been announced for Abterra Biosciences.
How can I track Abterra Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Abterra Biosciences's shares on secondary markets.